Sebastian Ewen

Showing 1-11 of 11 articles

Coronary interventions

Randomized Comparison of Bare Metal or Drug-Eluting Stent versus Drug Coated Balloon in Non-ST-Elevation Myocardial Infarction - PEPCAD NSTEMI

Scheller B, Ohlow M, Ewen S, Kische S, Rudolph T, Clever Y, Wagner A, Richter S, El-Garhy M, Böhm M, Degenhardt R, Mahfoud F, Lauer B, Brachmann J, Bärisch A

October 29, 2019 | 10.4244/EIJ-D-19-00723

Will SPYRAL HTN-ON MED change my practice? SPYRAL HTN-ON MED: a prospective, randomised, sham-controlled trial on renal denervation in the presence of antihypertensive medications

Ewen S, Lauder L, Azizi M, Kandzari D, Pathak A, Sharif F, Wijns W, Mahfoud F, Lüscher T

August 3, 2018 | 10.4244/EIJY18M07_1

Will SPYRAL HTN-OFF MED change my practice? SPYRAL HTN-OFF MED: a prospective, randomised, sham-controlled trial on renal denervation in the absence of antihypertensive medications

Lauder L, Ewen S, Azizi M, Mauri L, Lurz P, Lobo M, Sharif F, Wijns W, Tsioufis C, Mahfoud F

August 3, 2018 | 10.4244/EIJY18M07_2

Other

Renal artery anatomy assessed by quantitative analysis of selective renal angiography in 1,000 patients with hypertension

Lauder L, Ewen S, Tzafriri A, Edelman E, Lüscher T, Blankestijn P, Dorr O, Schlaich M, Sharif F, Voskuil M, Zeller T, Ukena C, Scheller B, Böhm M, Mahfoud F

May 20, 2018 | 10.4244/EIJ-D-18-00112

Interventions for hypertension

Will SPRINT change my practice? SPRINT: a randomised trial of intensive versus standard blood-pressure control

Ewen S, Lobo M, Pathak A, Schmieder R, Tsioufis C, Wijns W, Mahfoud F

August 20, 2016 | 10.4244/EIJV12I6A132

Renal sympathetic nerve denervation using intraluminal ultrasound within a cooling balloon preserves the arterial wall and reduces sympathetic nerve activity

Pathak A, Coleman L, Roth A, Stanley J, Bailey L, Markham P, Ewen S, Morel C, Despas F, Honton B, Senard J, Fajadet J, Mahfoud F

August 20, 2015 | 10.4244/EIJV11I4A96

From SYMPLICITY HTN-3 to the Renal Denervation Global Registry: where do we stand and where should we go?

Pathak A, Ewen S, Fajadet J, Honton B, Mahfoud F, Marco J, Schlaich M, Schmieder R, Tsioufis C, Ukena C, Zeller T

May 20, 2014 | 10.4244/EIJV10I1A4

Response and non-response to renal denervation: who is the ideal candidate?

Ukena C, Cremers B, Ewen S, Böhm M, Mahfoud F

May 21, 2013 | 10.4244/EIJV9SRA10

Expanding the indication spectrum: renal denervation in diabetes

Mahfoud F, Ewen S, Ukena C, Linz D, Sobotka P, Cremers B, Böhm M

May 21, 2013 | 10.4244/EIJV9SRA20

Therapeutic potential of renal sympathetic denervation in patients with chronic heart failure

Böhm M, Ewen S, Linz D, Reil J-C, Schirmer S, Ukena C, Mahfoud F

May 21, 2013 | 10.4244/EIJV9SRA21

First-in-human experience: percutaneous renal denervation through a false lumen fenestration in aortic dissection type B

Ewen S, Mahfoud F, Böhm M

January 18, 2013 | 10.4244/EIJV8I9A170

Latest news

New issue

EHRA/EAPCI consensus on LAA occlusion, EAPCI Position paper on defining device sucess and more

(3D volume-rendered CCTA LAA example)

January 17, 2020

Editorial

From Paris to Amsterdam: EuroPCR, ESC 2020 and spotlight on “The Cutting Edge of Cardiology”

Robert Byrne

January 17, 2020

JAA

New this week: Inferior caval valve implantation for severe tricuspid regurgitation

January 14, 2020

TRIALS BOOK

Access some of the latest Trials: EXCEL 5 years, GALILEO, ISAR-REACT 5 ...

(The Trials book is supported by Biotronik)

January 15, 2020

Guidance Papers

Guidelines, consensus & position papers

April 9, 2019

Editorial

The role of the Heart Team in the planning of aortic valve replacement

January 15, 2020

JAA

Last week's JAA's: Paravalvular leak after TAVI & TAVI with ACURATE NEO

January 7, 2020

Sebastian Ewen

Latest news

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke